96 related articles for article (PubMed ID: 6209907)
1. Experimental study on antitumor activity and pharmacokinetics of cytosine arabinoside, cyclocytidine and BH-AC.
Takenaka T; Kimura K
Nihon Ketsueki Gakkai Zasshi; 1984 Jul; 47(4):938-49. PubMed ID: 6209907
[No Abstract] [Full Text] [Related]
2. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)].
Takenaka T; Kimura K
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2322-8. PubMed ID: 3831176
[No Abstract] [Full Text] [Related]
3. Comparative ultrastructure of submaxillary salivary glands from mice treated with cytosine arabinoside, cyclocytidine, and anhydro-ara-5-fluorocytidine.
Liss RH; Charest MC; Mead JA
Cancer Treat Rep; 1976 Jul; 60(7):881-8. PubMed ID: 64296
[TBL] [Abstract][Full Text] [Related]
4. [Cytarabine].
Ota K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2983-7. PubMed ID: 3478003
[TBL] [Abstract][Full Text] [Related]
5. Antiviral effect of antileukemic drugs N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) and 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus.
Nakamura K; Eizuru Y; Kumura K; Minamishima Y
J Med Virol; 1990 Jun; 31(2):141-7. PubMed ID: 1696958
[TBL] [Abstract][Full Text] [Related]
6. Comparison of some biochemical parameters of arabinosylcytosine and cyclocytidine in L1210 murine leukemia cells.
Novotný L; Reichelová V; Balázová E; Ujházy V
Neoplasma; 1990; 37(1):13-22. PubMed ID: 1690864
[TBL] [Abstract][Full Text] [Related]
7. Tyramine-like effect of cyclocytidine (2,2'-anhydro-1-beta-arabinofuranosylcytosine hydrochloride), an antineoplastic agent.
Oguro K; Hashimoto K
Tohoku J Exp Med; 1978 Jan; 124(1):83-90. PubMed ID: 76345
[TBL] [Abstract][Full Text] [Related]
8. Effect and toxicity of combination treatment including cyclocytidine or cytosine arabinoside in L-1210 and sarcoma-180 systems.
Hoshi A; Kanzawa F; Iigo M; Kuretani K
Gan; 1975 Oct; 66(5):539-46. PubMed ID: 1220992
[TBL] [Abstract][Full Text] [Related]
9. Mathematical model for cyclocytidine pharmacokinetics.
Himmelstein KJ; Gross JF
J Pharm Sci; 1977 Oct; 66(10):1441-4. PubMed ID: 72816
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of the malignancies from the viewpoint of pharmacology and biochemistry of cytosine arabinoside (ara-C) and its derivatives].
Nakamura T; Ueda T
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1339-51. PubMed ID: 6191711
[TBL] [Abstract][Full Text] [Related]
11. [The effects of 2, 2'-O-cyclocytidine (CC) and acyclovir (ACV) on latent herpes simplex virus in trigeminal ganglia of mice].
Liu WG; Ma ZX; Chen ZJ; Song JZ
Yao Xue Xue Bao; 1985 Oct; 20(10):732-6. PubMed ID: 2424263
[No Abstract] [Full Text] [Related]
12. Some cardiovascular effects of cyclocytidine.
Herman EH; Chadwick DP
Cancer Treat Rep; 1976 Nov; 60(11):1663-6. PubMed ID: 66094
[No Abstract] [Full Text] [Related]
13. Survival of L1210 leukemia cells and normal hematopoietic stem cells following in vivo administration of cyclocytidine.
Valeriote F; Muntz ID; Vietti TJ
Invest New Drugs; 1985; 3(3):255-61. PubMed ID: 2415478
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and cytosine arabinoside in the treatment of murine brain tumor.
Basler GA; Shapiro WR
Cancer Treat Rep; 1976 Jul; 60(7):875-9. PubMed ID: 64295
[TBL] [Abstract][Full Text] [Related]
15. [Combined therapy of acyclovir and cyclocytidine against herpes simplex virus].
Chen ZJ; Liu WG; Song JZ; Zhang Y
Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):364-6. PubMed ID: 2461639
[No Abstract] [Full Text] [Related]
16. Distribution and excretion of 14C-cyclocytidine in experimental animals.
El Dareer SM; White VM; Tillery K; Chen FP; Mellett LB; Hill DL
Cancer Treat Rep; 1977 Aug; 61(5):805-14. PubMed ID: 70271
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells.
Maehara Y; Kusumoto T; Sakaguchi Y; Kusumoto H; Anai H; Sugimachi K
Anticancer Res; 1989; 9(1):41-4. PubMed ID: 2705754
[TBL] [Abstract][Full Text] [Related]
18. Aqueous conversion kinetics and mechanisms of ancitabine, a prodrug of the antileukemic agent cytarabine.
Kirsch LE; Notari RE
J Pharm Sci; 1984 Jul; 73(7):896-902. PubMed ID: 6206222
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic prodrug modeling: in vitro and in vivo kinetics and mechanisms of ancitabine bioconversion to cytarabine.
Kirsch LE; Notari RE
J Pharm Sci; 1984 Jun; 73(6):728-32. PubMed ID: 6204036
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in mice.
Liss RH; Neil GL
Cancer Chemother Rep; 1975; 59(3):501-13. PubMed ID: 1203880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
